The FDA grants RPDD for serious and life-threatening diseases that primarily affect children ages 18 years or younger and fewer than 200,000 people in the U.S. There are approximately 100,000 people ...

An oral investigational agent, gildeuretinol (ALK-001), demonstrated a significant reduction in geographic atrophy (GA) ...

A recent analysis reveals a strong link between photoreceptor health and visual function in geographic atrophy, emphasizing ...

A recent study reveals how geographic atrophy affects patients' vision and quality of life, highlighting their coping ...

Over time, it spreads to other parts of your retina. This leads to more vision loss. After a few years, your vision may decline to legal blindness. Learning more about geographic atrophy can ...

As AMD progresses, the loss of retinal cells and the underlying blood vessels in the macula results in marked thinning and/or atrophy of retinal tissue. Geographic atrophy, associated with AMD, leads ...

but we later identified the correct issue as gyrate atrophy with advanced cataracts and cystoid macular edema. Both conditions can present peripheral vision loss or changes in the retina.” ...

Similar drusen-like deposits were regularly seen in the peripheral fundus, predominantly temporally and often with a radial distribution. Two patients showed a bilateral chorioretinal atrophy and two ...

With only 2 eyes with peripheral GA included in the current study, no meaningful conclusions could be drawn related to commonality of the lesions or their growth rates. “Although fundus ...

Alkeus Pharmaceuticals, Inc, a biopharma company dedicated to preserving the sight of individuals impacted by retinal diseases, announced that patients with geographic atrophy secondary to age-related ...

The high contrast of RGB images enhanced the visibility of peripheral retinal ... such as drusen, retinal exudates, superficial retinal hemorrhages, neovascularization, ghost vessels, and ...